PubMed

Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes.

Hsueh WA, Jackson S, Law RE.

Diabetes Care. 2001 Feb;24(2):392-7. Review.PMID: 11213897 [PubMed - indexed for MEDLINE]Related articlesFree article

PPARgamma and atherosclerosis: effects on cell growth and movement.

Hsueh WA, Law RE.

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1891-5. Review.PMID: 11742860 [PubMed - indexed for MEDLINE]Related articlesFree article

PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.

Goetze S, Xi XP, Kawano H, Gotlibowski T, Fleck E, Hsueh WA, Law RE.

J Cardiovasc Pharmacol. 1999 May;33(5):798-806.PMID: 10226869 [PubMed - indexed for MEDLINE]Related articles

Vascular protective effects by activation of nuclear receptor PPARgamma.

Wakino S, Law RE, Hsueh WA.

J Diabetes Complications. 2002 Jan-Feb;16(1):46-9. Review.PMID: 11872366 [PubMed - indexed for MEDLINE]Related articles

Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.

Bruemmer D, Yin F, Liu J, Berger JP, Sakai T, Blaschke F, Fleck E, Van Herle AJ, Forman BM, Law RE.

Circ Res. 2003 Aug 22;93(4):e38-47. Epub 2003 Jul 24.PMID: 12881480 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic and additional vascular effects of thiazolidinediones.

Martens FM, Visseren FL, Lemay J, de Koning EJ, Rabelink TJ.

Drugs. 2002;62(10):1463-80. Review.PMID: 12093315 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.

Duan SZ, Usher MG, Mortensen RM.

Circ Res. 2008 Feb 15;102(3):283-94. Review.PMID: 18276926 [PubMed - indexed for MEDLINE]Related articlesFree article

Hypertension and insulin resistance: role of peroxisome proliferator-activated receptor gamma.

Itoh H, Doi K, Tanaka T, Fukunaga Y, Hosoda K, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Nakao K.

Clin Exp Pharmacol Physiol. 1999 Jul;26(7):558-60.PMID: 10405788 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.

Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB.

Kidney Int. 2001 May;59(5):1899-910.PMID: 11318962 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression and function of PPARgamma in rat and human vascular smooth muscle cells.

Law RE, Goetze S, Xi XP, Jackson S, Kawano Y, Demer L, Fishbein MC, Meehan WP, Hsueh WA.

Circulation. 2000 Mar 21;101(11):1311-8.PMID: 10725292 [PubMed - indexed for MEDLINE]Related articlesFree article

Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells.

Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Kudo M, Sato K, Taniyama Y, Ito S.

Endocrinology. 2001 Jul;142(7):3125-34.PMID: 11416035 [PubMed - indexed for MEDLINE]Related articlesFree article

[Anti-atherosclerotic effects of PPAR gamma ligands]

Wakino S.

Nippon Rinsho. 2004 Jan;62(1):180-6. Review. Japanese. PMID: 14737851 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptors and the cardiovascular system.

Chen YE, Fu M, Zhang J, Zhu X, Lin Y, Akinbami MA, Song Q.

Vitam Horm. 2003;66:157-88. Review.PMID: 12852255 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.

Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, Al-Omran M, Cherng WJ, Li RK, Stanford WL, Verma S.

Circulation. 2004 Mar 23;109(11):1392-400. Epub 2004 Mar 1.PMID: 14993120 [PubMed - indexed for MEDLINE]Related articlesFree article

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.

Chinetti G, Fruchart JC, Staels B.

Z Kardiol. 2001;90 Suppl 3:125-32. Review.PMID: 11374025 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3.

Fu M, Zhang J, Zhu X, Myles DE, Willson TM, Liu X, Chen YE.

J Biol Chem. 2001 Dec 7;276(49):45888-94. Epub 2001 Oct 5.PMID: 11590167 [PubMed - indexed for MEDLINE]Related articlesFree article

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.

Collins AR, Meehan WP, Kintscher U, Jackson S, Wakino S, Noh G, Palinski W, Hsueh WA, Law RE.

Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):365-71.PMID: 11231915 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes mellitus and macrovascular disease: mechanisms and mediators.

Boyle PJ.

Am J Med. 2007 Sep;120(9 Suppl 2):S12-7. Review.PMID: 17826041 [PubMed - indexed for MEDLINE]Related articles

Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells.

Sugawara A, Uruno A, Kudo M, Ikeda Y, Sato K, Taniyama Y, Ito S, Takeuchi K.

J Biol Chem. 2002 Mar 22;277(12):9676-83. Epub 2002 Jan 2.PMID: 11777901 [PubMed - indexed for MEDLINE]Related articlesFree article

Peroxisome proliferator-activated receptor-gamma in vascular biology.

Li J, Wang N.

Cardiovasc Hematol Disord Drug Targets. 2007 Jun;7(2):109-17. Review.PMID: 17584045 [PubMed - indexed for MEDLINE]Related articles